Net Cash Provided by (Used in) Financing Activities of BIOMERICA INC from 31 Aug 2010 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOMERICA INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Aug 2010 to 31 Aug 2025.
  • BIOMERICA INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Aug 2025 was $920,000.
  • BIOMERICA INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $2,111,000.
  • BIOMERICA INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $81,000, a 101% decline from 2022.
  • BIOMERICA INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9,390,000, a 292% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOMERICA INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $920,000 01 Jun 2025 31 Aug 2025 10-Q 14 Oct 2025 2026 Q1
Q3 2022 $1,778,000 +$973,394 +121% 01 Jun 2022 31 Aug 2022 10-Q 12 Oct 2023 2024 Q1
Q3 2021 $804,606 +$789,706 +5300% 01 Jun 2021 31 Aug 2021 10-Q 13 Oct 2022 2023 Q1
Q3 2020 $14,900 -$131,736 -90% 01 Jun 2020 31 Aug 2020 10-Q 14 Oct 2021 2022 Q1
Q3 2019 $146,636 -$50,743 -26% 01 Jun 2019 31 Aug 2019 10-Q 15 Oct 2020 2021 Q1
Q3 2018 $197,379 +$196,341 +18915% 01 Jun 2018 31 Aug 2018 10-Q 15 Oct 2019 2020 Q1
Q3 2017 $1,038 01 Jun 2017 31 Aug 2017 10-Q 15 Oct 2018 2019 Q1
Q3 2015 $6,624 +$9,703 01 Jun 2015 31 Aug 2015 10-Q 17 Oct 2016 2017 Q1
Q3 2014 $3,079 -$3,839 -505% 01 Jun 2014 31 Aug 2014 10-Q 15 Oct 2015 2016 Q1
Q3 2013 $760 +$43,760 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2014 2015 Q1
Q3 2012 $43,000 -$31,274 -267% 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013 2014 Q1
Q3 2011 $11,726 -$686 -6.2% 01 Jun 2011 31 Aug 2011 10-Q 12 Oct 2012 2013 Q1
Q3 2010 $11,040 01 Jun 2010 31 Aug 2010 10-Q/A 27 Oct 2011 2012 Q1

BIOMERICA INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,111,000 +$2,192,000 01 Jun 2024 31 May 2025 10-K 29 Aug 2025 2025 FY
2023 $81,000 -$9,471,000 -101% 01 Jun 2023 31 May 2024 10-K 29 Aug 2025 2025 FY
2022 $9,390,000 +$6,996,000 +292% 01 Jun 2022 31 May 2023 10-K 28 Aug 2024 2024 FY
2021 $2,394,000 +$1,280,270 +115% 01 Jun 2021 31 May 2022 10-K 25 Aug 2023 2023 FY
2020 $1,113,730 -$11,260,247 -91% 01 Jun 2020 31 May 2021 10-K 29 Aug 2022 2022 FY
2019 $12,373,977 +$10,466,550 +549% 01 Jun 2019 31 May 2020 10-K/A 14 Oct 2021 2021 FY
2018 $1,907,427 +$613,120 +47% 01 Jun 2018 31 May 2019 10-K 31 Aug 2020 2020 FY
2017 $1,294,307 +$1,136,579 +721% 01 Jun 2017 31 May 2018 10-K 29 Aug 2019 2019 FY
2016 $157,728 -$948,186 -86% 01 Jun 2016 31 May 2017 10-K 29 Aug 2018 2018 FY
2015 $1,105,914 +$1,096,354 +11468% 01 Jun 2015 31 May 2016 10-K 29 Aug 2017 2017 FY
2014 $9,560 -$175,715 -95% 01 Jun 2014 31 May 2015 10-K 29 Aug 2016 2016 FY
2013 $185,275 -$73,239 -28% 01 Jun 2013 31 May 2014 10-K 31 Aug 2015 2015 FY
2012 $258,514 +$203,114 +367% 01 Jun 2012 31 May 2013 10-K 29 Aug 2014 2014 FY
2011 $55,400 +$17,509 +46% 01 Jun 2011 31 May 2012 10-K 29 Aug 2013 2013 FY
2010 $37,891 01 Jun 2010 31 May 2011 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.